title: Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study.
abstract: OBJECTIVE
  To document the rate of diagnostic certainty, co-morbidity and use of medication in patients with presumed obstructive airway disease (OAD) in a primary care setting.
  
  
  METHODS
  Twenty-six general practitioners (GPs) were asked to select the last 50 contacts with patients older than 40 years of age who were taking bronchodilators and/or inhaled corticosteroids or who had known OAD. After reviewing their medical data on file, the GPs gave their diagnostic opinion and rated their certainty about the diagnosis using a Likert-type scale.
  
  
  RESULTS
  Analysis of 1126 files revealed that in at least 523 patients (46.4%), a diagnostic work-up was judged necessary. The GPs judged that 6% of the patients had no OAD. Less than 33% of the study population underwent spirometry during the two years preceding the survey. The number of co-morbid conditions was on average 2.2 for patients with asthma and 3.2 for patients with COPD. Patients with presumed COPD took significantly more drugs (mean, 5.1; 95% CI, 4.8-5.3) than did patients with other diagnostic labels (mean, 4.6 95%; CI, 4.4-4.8).
  
  
  CONCLUSIONS
  We confirmed the underuse of spirometry as a diagnostic tool in presumed airway obstruction in primary care. Nearly half of the patients older than 40 years who were taking bronchodilators and/or inhaled corticosteroids needed a diagnostic work-up. This population had a high prevalence of co-morbidity and polypharmacy.
authors.affiliation: Department of General Practice, K.U.Leuven, Leuven, Belgium. johan.buffels@med.kuleuven.be
authors.forename: Johan
authors.initials: J
authors.lastname: Buffels
authors.forename: Jan
authors.initials: J
authors.lastname: Degryse
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Liistro
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001249:Asthma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D001530:Belgium; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002983:Clinical Competence / Q000706:statistics & numerical data*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D010821:Physicians, Family; D019338:Polypharmacy; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D012189:Retrospective Studies; D013147:Spirometry / Q000706:statistics & numerical data*
chemical_list: D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents